SCHEMBL794836

SCHEMBL794836

CC(=O)NCC(O)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10403069 0.79
SCHEMBL795358 0.77 KDM4E (0.44)
SCHEMBL5155262 0.74
SCHEMBL10404787 0.74
SCHEMBL5155266 0.74
SCHEMBL10402121 0.74
SCHEMBL7826230 0.74
SCHEMBL1866034 0.74 KDM4E (0.43)
SCHEMBL13411703 0.74 KDM4E (0.43)
SCHEMBL1866035 0.74 KDM4E (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9271993-B2 Treatment of bacterial infectious diseases UNIVERSITY OF ZURICH (CH) 2016-03-01 US disclosed
EP-2616079-B1 TREATMENT OF BACTERIAL INFECTIOUS DISEASES UNIV ZÜRICH (CH) 2015-10-14 EP disclosed
EP-2616079-A1 TREATMENT OF BACTERIAL INFECTIOUS DISEASES University of Zürich (CH) 2013-07-24 EP disclosed
US-20130165397-A1 TREATMENT OF BACTERIAL INFECTIOUS DISEASES ETH ZURICH (CH) 2013-06-27 US disclosed
WO-2012034955-A1 TREATMENT OF BACTERIAL INFECTIOUS DISEASES UNIVERSITY OF ZURICH (CH) 2012-03-22 WO disclosed
US-4914206-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-03 US disclosed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP disclosed